August 11, 2023
Novartis Completes Acquisition of Chinook Therapeutics
July 28, 2023
Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 Beyond Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy
June 17, 2023
Chinook Therapeutics Presents Data From Chk-336 Phase 1 Trial in Healthy Volunteers And New Insights Into the Role of Failed Repair in Chronic Kidney Disease at the 60th European Renal Association (Era) Congress
No current content.